Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-01-22FDA Approved: XOPENEX HFA — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for XOPENEX HFA (levalbuterol tartrate).
-
CLINICAL_TRIALS trial_result · 2016-01-22Clinical Trial Update: Location and Timing of Inhaler Use, Exacerbations and Physical Activity in Chronic Obstructive Pulmonary Disease
A completed clinical trial from VA Puget Sound Health Care System examining how the location and timing of inhaler use relate to exacerbatio…
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: Chronic Obstructive Pulmonary Disease Gene Localization
A completed clinical trial conducted by the University of Utah investigates gene localization in chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2) [Phase 3]
Phase 3 OTEMTO 2 results for the tiotropium/olodaterol fixed-dose combination in chronic obstructive pulmonary disease were posted in Januar…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD Patients [Phase 4]
Phase 4 trial comparing QVA149 (indacaterol/glycopyrronium) with tiotropium in COPD patients, focusing on lung function and patient preferen…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Fluticasone Propionate/Salmeterol (FSC) 250/50 Microgram (mcg) Through a Capsule-Based Inhaler and a Multi-Dose Inhaler Administered Twice Daily (BID) in Adults With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 non-inferiority trial evaluating the efficacy, safety, and tolerability of Fluticasone Propionate/Salmeterol 250/50 mcg delivered by…
-
CLINICAL_TRIALS research · 2016-01-18Clinical Trial Update: Adjusting to Chronic Conditions Using Education, Support, and Skills [NA]
A completed VA-sponsored trial evaluating education, support, and skills to help patients with chronic conditions (COPD, heart failure, and …
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: A Clinical Evaluation of the Oxitone Non-invasive Oximeter
This document provides an update on a clinical evaluation of the Oxitone non-invasive oximeter, assessing its performance in patients with C…
-
FDA approval · 2016-01-15FDA Approved: SPIRIVA RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approves a supplemental application for Spiriva Respimat (tiotropium bromide inhalation spray) from Boehringer Ingelheim Pharmaceuticals…
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: The COPD Patient Management European Trial (COMET) [Phase 4]
Phase 4 clinical trial update for the COPD Patient Management European Trial (COMET). The study status is completed.
-
CLINICAL_TRIALS withdrawal · 2016-01-12Clinical Trial Update: Safety Study of Nebivolol for COPD Patients [Phase 2, Phase 3]
A Phase 2/Phase 3 safety study of Nebivolol for chronic obstructive pulmonary disease was withdrawn.
-
CLINICAL_TRIALS research · 2016-01-12Clinical Trial Update: A Study of Inhaler Use in the Community
A completed clinical trial from Beaumont Hospital evaluating inhaler use in the community for asthma and chronic obstructive pulmonary disea…
-
CLINICAL_TRIALS withdrawal · 2016-01-12Clinical Trial Update: Opioids for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease [Phase 3]
A Phase 3 trial evaluating opioids for refractory breathlessness in chronic obstructive pulmonary disease has been withdrawn.
-
FDA approval · 2016-01-10FDA Approved: ACETYLCYSTEINE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Acetylcysteine from Fresenius Kabi USA, LLC, under an ANDA.
-
CLINICAL_TRIALS trial_result · 2016-01-07Clinical Trial Update: Pharmacokinetics and Safety of BI 1744 CL Plus Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) [Phase 1]
Phase 1 study reports pharmacokinetics and safety of BI 1744 CL when combined with tiotropium bromide in chronic obstructive pulmonary disea…
-
CLINICAL_TRIALS trial_result · 2016-01-06Clinical Trial Update: Apoptotic Cell (AC) Uptake by Human Alveolar Macrophages (AM)
Clinical trial update regarding apoptotic cell uptake by human alveolar macrophages in individuals with Chronic Obstructive Pulmonary Diseas…
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Single Leg Cycling in COPD: Knowledge Translation to Pulmonary Rehabilitation [NA]
A completed clinical trial evaluating single-leg cycling as a knowledge translation strategy for pulmonary rehabilitation in chronic obstruc…
-
CLINICAL_TRIALS research · 2016-01-01Clinical Trial Update: Adipose Derived Stem Cells Transplantation for Chronic Obstructive Pulmonary Disease [Phase 1, Phase 2]
A clinical trial update describes a Phase 1/Phase 2 study evaluating autologous adipose-derived stem cell transplantation for chronic obstru…
-
CLINICAL_TRIALS other · 2016-01-01Clinical Trial Update: The Short Physical Performance Battery in Chronic Obstructive Pulmonary Disease (COPD) [NA]
The record indicates the clinical trial evaluating the Short Physical Performance Battery in chronic obstructive pulmonary disease has compl…
-
CLINICAL_TRIALS trial_result · 2015-12-31Clinical Trial Update: Effects of CPAP Level on Respiratory Mechanics and Central Drive in Patients With COPD [NA]
A completed clinical trial evaluating how different CPAP levels influence respiratory mechanics and central drive in patients with Chronic O…
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: Effect of Inhaled Fentanyl on Dyspnea and Exercise Tolerance in Chronic Obstructive Pulmonary Disease (COPD) [NA]
Clinical trial evaluating inhaled fentanyl for dyspnea and exercise tolerance in chronic obstructive pulmonary disease has completed with re…
-
CLINICAL_TRIALS trial_result · 2015-12-29Clinical Trial Update: Trial of Inspiratory Muscle Rest and Exercise in Chronic Obstructive Lung Disease [Phase 3]
Phase 3 trial evaluating inspiratory muscle rest and exercise in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-29Clinical Trial Update: Randomized Trial of Physical Activity Self-Management Intervention for Patients With COPD [NA]
This update reports the completion of a randomized trial evaluating a physical activity self-management program for patients with COPD.
-
CLINICAL_TRIALS withdrawal · 2015-12-29Clinical Trial Update: Use of the Hattler Respiratory Assist Catheter in Severe Respiratory Failure [Phase 3]
A Phase 3 trial evaluating the Hattler Respiratory Assist Catheter for severe respiratory failure has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-12-24Clinical Trial Update: Disability and Health Outcomes in COPD
This clinical trial evaluating disability and health outcomes in chronic obstructive pulmonary disease has completed.